Bengaluru: The U.S. Food and Drug Administration has told medical device maker Medline that its syringes used in heart procedures are defective and warned the company of penal actions if it fails to ...
The company removed the devices from the market in February following complaints of the syringes disconnecting from manifolds ...
MDLN faces FDA warning over cGMP lapses in angiographic syringes, citing weak quality controls, CAPA gaps and design flaws ...
Clifford Gevirtz, MD, is employed by RAA of New York and practices anesthesiology throughout New York and Long Island, N.Y. RAA is managed by Somnia. Q: As a practicing consultant pharmacist to ...
FILE PHOTO: Signage is seen outside of the Food and Drug Administration headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo April 8 (Reuters) - The U.S. Food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results